MedicaidPrior AuthMedium impact
KMAP BULLETIN: Pharmaceutical Prior Authorization Updates
Kansas Medicaid (KanCare)·KS · Neurology, Gastroenterology, Allergy & Immunology +4 more·Provider Bulletin
Effective date
Dec 16, 2024
We identified it
Jun 21, 2026
Summary
Effective December 16, 2024, Kansas Medicaid (KMAP) requires clinical prior authorization for 15 specific medications including specialized treatments for rare diseases, immune globulin products, and neurological medications. KanCare MCOs may implement this policy on different dates, so providers should monitor the Open Claims Resolution Log for specific MCO implementation timelines.
Action Required
Immediately: Clinical staff must obtain prior authorization before prescribing or administering the 15 listed medications for Kansas Medicaid patients. Update EMR templates to flag these medications: Lenmeldy, Onyda XR, Iqirvo, Duvyzat, Panzyga, Hyqvia, Xembify, Asceniv, Alyglo, Cuvitru, Cutaquig, Ocaliva, Livdelzi, Ingrezza Sprinkle, and Agamree. Monitor the KMAP Open Claims Resolution Log for MCO-specific implementation dates as timing may vary by plan.